Fiserv Inc. Common Stock vs Tilray Brands Inc — how do they compare? Fiserv Inc. Common Stock trades at $46.97 (market cap $24.50B), while Tilray Brands Inc trades at $3.23 (market cap $463.31M). The key difference: Fiserv Inc. Common Stock is far larger — about 52.9× Tilray Brands Inc's market cap, and Tilray Brands Inc is more actively traded (4,627,093 versus 3,682,634). Which is the better fit depends on your goals — on Pluang, investors hold Fiserv Inc. Common Stock for 0 Days and Tilray Brands Inc for 31 Days on average.
| FISV | TLRY | |
|---|---|---|
Market Cap | $24.50B | $463.31M |
Volume | 3,682,634 | 4,627,093 |
Sector | Technology | Health |
52-Week High | $126.54 | $16.80 |
52-Week Low | $44.36 | $3.14 |
Typical Hold Time | 0 Days | 31 Days |
Enterprise Value | $52.29B | $617.23M |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
TLRY trades at $3.17, down 3.06% on the day and near its 52-week low, reflecting persistent bearish sentiment. The stock exhibits weak fundamentals with a net income margin of -17.05% and negative cash flow from operations of -$94.60M in 2025. Recent earnings have consistently missed expectations, and technical indicators signal a bearish trend. However, the company maintains a diversified portfolio in cannabis, beverages, and wellness, with revenue growth projected to $963M in 2026.
The outlook remains challenging due to ongoing losses and high debt, but a low P/S ratio of 0.39 and analyst consensus price target of $65.01 suggest potential long-term upside if profitability improves. Key risks include regulatory uncertainty, competitive pressures, and reliance on financing activities to sustain operations.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Fiserv, Inc. is a global provider of payments and financial services technology, offering merchant acquiring, digital commerce, and financial solutions through its Merchant Solutions and Financial Solutions segments.
Read more on FISV →Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →